|
CN101287742B
(zh)
|
2005-10-12 |
2016-01-06 |
艾德拉药物股份有限公司 |
基于变异应答调制Toll样受体的免疫调节寡核苷酸(IRO)化合物
|
|
JP2010522697A
(ja)
*
|
2007-03-16 |
2010-07-08 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション |
キナーゼタンパク質結合阻害剤
|
|
CN102281880A
(zh)
*
|
2008-10-06 |
2011-12-14 |
艾德拉药物股份有限公司 |
类Toll受体抑制剂在高胆固醇血症和高脂血症及相关疾病的预防和治疗中的用途
|
|
SG171914A1
(en)
|
2008-12-02 |
2011-07-28 |
Chiralgen Ltd |
Method for the synthesis of phosphorus atom modified nucleic acids
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
RU2011135993A
(ru)
*
|
2009-01-30 |
2013-03-10 |
Идера Фармасьютикалз, Инк. |
Новые синтетические агонисты tlr9
|
|
AU2010229835B2
(en)
|
2009-03-25 |
2015-01-15 |
The Board Of Regents Of The University Of Texas System |
Compositions for stimulation of mammalian innate immune resistance to pathogens
|
|
EP2451461A4
(en)
|
2009-07-06 |
2013-05-29 |
Ontorii Inc |
NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
|
|
WO2011005942A2
(en)
*
|
2009-07-08 |
2011-01-13 |
Idera Pharmaceuticals, Inc. |
Oligonucleotide-based compounds as inhibitors of toll-like receptors
|
|
TR201809739T4
(tr)
*
|
2009-07-16 |
2018-07-23 |
Mallinckrodt Llc |
Toll benzeri reseptör 9 antagonistleri olarak (+)-morfinanlar ve bunların terapötik amaçlı kullanımları.
|
|
US10363251B2
(en)
|
2009-07-16 |
2019-07-30 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
SI2470656T1
(sl)
*
|
2009-08-27 |
2015-07-31 |
Idera Pharmaceuticals, Inc. |
Sestavek za inhibicijo ekspresije genov in njegova uporaba
|
|
US9415046B2
(en)
|
2009-09-29 |
2016-08-16 |
Yale University |
Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
|
|
JP2011084517A
(ja)
*
|
2009-10-15 |
2011-04-28 |
Koreaki Taniguchi |
核酸により活性化される自然免疫応答の抑制剤及びスクリーニング方法
|
|
EP2550360B1
(en)
*
|
2010-03-24 |
2017-08-30 |
Mirrx Therapeutics A/s |
Bivalent antisense oligonucleotides
|
|
ES2728701T3
(es)
|
2010-07-16 |
2019-10-28 |
Mallinckrodt Llc |
(+)-Morfinanos como antagonistas del receptor 9 de tipo Toll y aplicaciones terapéuticas de los mismos
|
|
GB201014026D0
(en)
*
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
|
US9186371B2
(en)
|
2010-09-17 |
2015-11-17 |
Japan Science And Technology Agency |
Inhibitor of HMGB protein-mediated immune response activation, and screening method
|
|
DK2620428T3
(da)
|
2010-09-24 |
2019-07-01 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
JP5813778B2
(ja)
|
2010-11-19 |
2015-11-17 |
イデラ ファーマシューティカルズ インコーポレイテッドＩｄｅｒａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
トール様受容体に基づく免疫反応を調節するための免疫調節オリゴヌクレオチド（ｉｒｏ）化合物
|
|
GB201022049D0
(en)
*
|
2010-12-29 |
2011-02-02 |
Imp Innovations Ltd |
Methods
|
|
US8877722B2
(en)
*
|
2011-03-25 |
2014-11-04 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting gene expression and uses thereof
|
|
US9050359B2
(en)
*
|
2011-05-16 |
2015-06-09 |
Haus Bioceuticals Inc. |
Compositions of herbal formulations and uses thereof
|
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
|
JP6129844B2
(ja)
|
2011-09-14 |
2017-05-17 |
ラナ セラピューティクス インコーポレイテッド |
多量体オリゴヌクレオチド化合物
|
|
CN112007045B
(zh)
|
2012-07-13 |
2026-01-06 |
波涛生命科学有限公司 |
手性控制
|
|
JP6246121B2
(ja)
*
|
2012-07-13 |
2017-12-13 |
株式会社新日本科学 |
キラル核酸アジュバント
|
|
DK2872485T3
(da)
|
2012-07-13 |
2021-03-08 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
CA2884608C
(en)
|
2012-09-14 |
2025-05-20 |
Translate Bio Ma, Inc. |
MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS
|
|
CN103845731B
(zh)
*
|
2012-12-05 |
2015-12-02 |
复旦大学 |
抗st2/il-1r4抗体在制备防治瘙痒药物中的应用
|
|
CN103845730B
(zh)
*
|
2012-12-05 |
2015-12-09 |
复旦大学 |
抗st2/il-1 r4抗体在制备镇痛药物中的用途
|
|
KR101898177B1
(ko)
*
|
2013-01-08 |
2018-09-12 |
이데라 파마슈티칼즈, 인코포레이티드 |
톨－유사 수용체 기반 면역 반응을 조절하기 위한 면역 조절 올리고누클레오티드 （ｉｒｏ） 화합물
|
|
CA2840974A1
(en)
*
|
2013-02-05 |
2014-08-05 |
Nitto Denko Corporation |
Vaccine composition for mucosal administration
|
|
GB2514591A
(en)
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
EP3095461A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
KR102423317B1
(ko)
|
2014-01-16 |
2022-07-22 |
웨이브 라이프 사이언시스 리미티드 |
키랄 디자인
|
|
EP3164113B1
(en)
|
2014-06-04 |
2019-03-27 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
US11213593B2
(en)
|
2014-11-21 |
2022-01-04 |
Northwestern University |
Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
SK500652015A3
(sk)
|
2015-10-15 |
2017-05-03 |
Ústav Polymérov Sav |
Spôsob úpravy funkčného stavu ľubovoľnej mRNA umožňujúci jej selektívne a špecifické rozpoznanie
|
|
CN105597079A
(zh)
*
|
2016-01-11 |
2016-05-25 |
中国人民解放军第三军医大学第一附属医院 |
用于治疗银屑病的药物
|
|
CN105541947A
(zh)
*
|
2016-01-11 |
2016-05-04 |
中国人民解放军第三军医大学第一附属医院 |
拮抗tlr7/8及tlr9活化的药物分子及用途
|
|
EP3468605A4
(en)
|
2016-06-08 |
2020-01-08 |
President and Fellows of Harvard College |
MANIPULATED VIRAL VECTOR TO REDUCE INDUCTION OF IGNITION AND IMMUNE REACTIONS
|
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
|
EP3538513A1
(en)
|
2016-11-11 |
2019-09-18 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
CA3044484A1
(en)
*
|
2016-11-23 |
2018-05-31 |
Berlin Cures GmbH |
Aptamers for use in inhibition and/or suppression of tlr9 activation
|
|
WO2018209270A1
(en)
|
2017-05-11 |
2018-11-15 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (snas)
|
|
US11473145B2
(en)
|
2017-07-27 |
2022-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for determining whether a patient suffering from rhabdomyolysis achieves a response with a TLR9 antagonist
|
|
AU2018364542A1
(en)
|
2017-11-08 |
2020-04-16 |
President And Fellows Of Harvard College |
Compositions and methods for inhibiting viral vector-induced inflammatory responses
|
|
SG11202011667WA
(en)
*
|
2018-05-25 |
2020-12-30 |
Primmune Therapeutics Inc |
Tlr7 agonists
|
|
PE20221324A1
(es)
|
2019-11-26 |
2022-09-09 |
Primmune Therapeutics Inc |
Agonistas del tlr7
|
|
MX2022005633A
(es)
*
|
2020-01-10 |
2022-06-14 |
Sbi Biotech Co Ltd |
Novedosos agonistas del receptor tipo toll 9 (tlr9).
|